Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.

Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT.

Am J Psychiatry. 2009 May;166(5):557-66. doi: 10.1176/appi.ajp.2008.08081170. Epub 2009 Mar 16.

2.

Does fetal exposure to SSRIs or maternal depression impact infant growth?

Wisner KL, Bogen DL, Sit D, McShea M, Hughes C, Rizzo D, Confer A, Luther J, Eng H, Wisniewski SW.

Am J Psychiatry. 2013 May;170(5):485-93. doi: 10.1176/appi.ajp.2012.11121873. Erratum in: Am J Psychiatry. 2013 Oct 1;70(10):1218.

3.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Epub 2016 May 30. Review.

4.

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.

Arch Gen Psychiatry. 2012 Jul;69(7):706-14. doi: 10.1001/archgenpsychiatry.2011.2333.

PMID:
22393202
5.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
6.

To treat or not to treat perinatal depression with antidepressant medication: effects on infant growth.

Parry BL.

Am J Psychiatry. 2013 May;170(5):453-4. doi: 10.1176/appi.ajp.2013.13010118. No abstract available.

PMID:
23511843
7.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
8.

The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.

Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.

Am J Psychiatry. 2016 Feb 1;173(2):147-57. doi: 10.1176/appi.ajp.2015.14080989. Epub 2015 Oct 30.

10.

Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.

Grzeskowiak LE, Gilbert AL, Morrison JL.

J Clin Psychopharmacol. 2012 Oct;32(5):615-21. doi: 10.1097/JCP.0b013e31826686bc.

PMID:
22926594
11.

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.

Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.

Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.

PMID:
23128923
12.

Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.

Colvin L, Slack-Smith L, Stanley FJ, Bower C.

CNS Drugs. 2012 Jul 1;26(7):e1-14. doi: 10.2165/11634190-000000000-00000.

13.

Outcomes of prenatal antidepressant exposure.

Simon GE, Cunningham ML, Davis RL.

Am J Psychiatry. 2002 Dec;159(12):2055-61.

PMID:
12450956
14.

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.

Lund N, Pedersen LH, Henriksen TB.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):949-54. doi: 10.1001/archpediatrics.2009.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Dec;163(12):1143.

PMID:
19805715
15.

Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.

Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF.

Pediatrics. 2009 Oct;124(4):e662-70. doi: 10.1542/peds.2009-0442. Epub 2009 Sep 28.

PMID:
19786426
16.

Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.

Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.

Psychopharmacology (Berl). 2011 Sep;217(2):211-9. doi: 10.1007/s00213-011-2270-z. Epub 2011 Apr 16.

PMID:
21499702
17.

Safety of SSRIs during pregnancy: a controlled study.

Altamura AC, De Gaspari IF, Rovera C, Colombo EM, Mauri MC, Fedele L.

Hum Psychopharmacol. 2013 Jan;28(1):25-8. doi: 10.1002/hup.2276. Epub 2012 Nov 20.

PMID:
23166037
18.

Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.

Nezvalov√°-Henriksen K, Spigset O, Brandlistuen RE, Ystrom E, Koren G, Nordeng H.

Int J Epidemiol. 2016 Dec 1;45(6):2018-2029. doi: 10.1093/ije/dyw049.

19.

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.

Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J.

Am J Psychiatry. 2007 Aug;164(8):1206-13.

PMID:
17671283
20.

Mother-infant antidepressant concentrations, maternal depression, and perinatal events.

Sit D, Perel JM, Wisniewski SR, Helsel JC, Luther JF, Wisner KL.

J Clin Psychiatry. 2011 Jul;72(7):994-1001. doi: 10.4088/JCP.10m06461.

Supplemental Content

Support Center